Member Info for SYN00GOLD

Wish you all the best Vik : My third top up of the day shows as a sell for 82,000 @ 16:08:19, but guess what, its a buy 🎁🎅🎄😊🎉

Meanwhile, I'm nibbling away, munch munch, slow and steady

Patience

Apologies : busy at work, should have read Avion : re, the reply

Hi XXXXXXXXXXX

Hope you're well

Avion continue to have sole US rights to P140, as per their agreement

Have a good day

Lisa

Lisa Baderoon

Non-Executive Director & Head of Investor Relations

ImmuPharma PLC

lisa.baderoon@immupharma.com

M: + 44 (0) 7721 413 496

www.immupharma.co.uk

I can confirm that the US have sole and exclusive rights to p140, informed by Immunopharma.

Also, have on good authority that a deal WILL be completed before end of Q1 26., it's just a matter of completion of negotiations and best deal for shareholders.

I agree. This is a share that will be in excess of 25p by end of Q1. I have just sold 416 AZN shares for £58K. I have 5000 AZN built up over years.

I will drip feed the £58,000 over the next 4 weeks into IMM. My IMM will be quite large come early 2026 !!!

Will not write here again, as become a cesspit of trolls. Will say hello again in 2026.

Wishing all true LTH's a happy and healthy Christmas. You either believe or you don't 🎀🎁🎉🎉😊😊🚀🚀🚀❄️🎅🎅🎄🎄🎅🎅

IMM has undertaken many actions and advanced its core mission of delivering P140 to patients. These actions include leadership changes, organisational changes (including our French scientists), strengthened long-term value with MoA proven and verified externally. Expect publication in next few months, after the DD room analysis by numerous parties. Created a diagnostic tool to de-risk future trials in P3 (whoever will be doing them, have a feeling it will be our 'partner', and filed a 20-year patent to enhance attractiveness.

Removed artificial deadlines and prioritized securing the best deal rather than the quickest. While delays and perceived over-optimism have caused frustration among some investors, committed shareholders WILL benefit as the company progresses toward its ultimate goal.

Patience as Mr Buffet always said. I remember everyone on BB's slagging off RR and that has done exceptionally well in past few years.

Our time is coming and I believe we will be very happy.

I'm thinking will they split the share down to £70 range, 2:1 ???, 4:1 ???

Great share to hold.

GG : I can corroborate your message !! Coming out this week. Share will jump 30-40% !!!

I'm holding a fixed number of shares and a trading pot for the spikes, I believe another spike will hit very soon, brace yourselves..............

My forecast is this will be above 12p by end of Jan 2026.

CDA's signed and >1 top 10 pharma doing DD. When the deal/deals land this will go exponentially higher. I can see minimum 40 -60p as a starter and if you are not in, you will miss out. I know of one top 10 pharma that is currently doing DD at Immupaharma.

Ignore the FUD, the usual suspects where at this when the SP was at less than a penny !!!! 🎁🎀🎁😊🎉🎉🎉

Totally agree Jock :

'The whole team is dedicated to securing a partnership deal that does justice to the innovation and clinical potential of P140, valuing a more methodical approach over speed, so the best outcome for shareholders can be achieved. We are seeking a partner whose culture and aspirations match those of the Board, prioritising long-term synergy.'

Nuff said 🎁🎀🎉😊

I have been bulk buying, some of my #s not showing yet. 99,947 @ 7.498 and 200,000 @ same !!!

This is Christmas come early for moi !!!!! This is gold. Patience is a virtue, when everyone is selling, buy, buy, buy

Soz, wrong board

Picked up another 200K shares : This is gold. Patience is a virtue, when everyone is selling, buy, buy, buy

Morning Wig - I would not waste your time and energy on some of the folks on here, I do not give them oxygen and have many filtered, it's a good feeling. I only know that I made over 1000% in IMM and have a free ride on what's left in (which is quite significant). I have faith in the premise that we hold the elixir with IMM and patience is a virtue. Good to know that Nolupus is still about !!! Take care and will post after the next RNS, which will make me close another 20% of my holding in this share.

Good health all.

from my *** pack calculations, imm have sufficient funding now into h1 2027 based on current costs. i'm sure the next update on revenues will confirm as much. so pretty confident, this is going upwards in the longer term, just need to all wait patiently for the 1st rns to land.

imm has just announced a groundbreaking patent for its lead asset p140, the world’s first “immunormalizer,” offering a precision diagnostic and treatment approach for autoimmune diseases. with potential 20-year exclusivity, the patent targets patients with the newly identified “type m” immune disorder, who are super-responders to p140, opening the door to safer, more effective therapies across up to 50 autoimmune conditions. this dual opportunity as both a first-in-class therapy and novel diagnostic test positions immupharma at the forefront of a $100bn treatment and $10bn diagnostics market.

the ceo does not give that many public announcements without total transparency and confidence. having worked on multiple due diligence efforts in the past with az and novartis, the detail takes time and under strict ndas.

hold tight and await the rewards 😊😉

.

Like a fool, I've added a chunk !! 🥴

Who knows the real truth until RNS is formally announced. I will be buying a lot more tomorrow as cheaply as I can, and would suspect the price will steadily rise towards 25-27 range towards end of day.

Morning Isle : I received the same type of message on Friday from a source at GS. The said the threshold had been passed to accept the 30p. It’s now just the bureaucracy of waiting till late Q1, which after this protracted period, I can.

I wish all long suffering shareholders all the best !!

Proxy votes of the major institutions have already decided this. If you go and read the key RNS statements previously issued were the BoD discuss the >75% requirement to accept the 30p. They know already. Sidara and the Bod had many meetings with key shareholders way in advance.

Monday’s meeting is box ticking and then RNS at 4.30pm to say vote outcome. Then within RNS plethora of notifications with respect to capital injection, the first $250 million from Sidara, amendment and extention with the bank facilities and the noteholders will go live simultaneous, the Annual Report that gives us access to $200 million of bonding lines etc etc